ASP Isotopes ASPI
ASP Isotopes Inc. · Nasdaq · Miscellaneous Chemical Products
$2.03-1.46%close on Oct. 28, 2026 · volume 3.1M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 16, 2026 | Heather Kiessling Chief Financial Officer | Sold | 21,830 | $2.19 | $47,808 |
| Oct. 14, 2026 | Robert Ainscow COO | Sold 10b5-1 plan | 22,500 | $2.11 | $47,565 |
| Sept. 30, 2026 | Robert John Andrew Ryan director | Bought | 15,000 | $2.68 | $40,200 |
| Sept. 28, 2026 | Robert John Andrew Ryan director | Bought | 8,000 | $2.70 | $21,600 |
| Sept. 8, 2026 | Robert Ainscow COO | Sold 10b5-1 plan | 8,438 | $4.29 | $36,216 |
| Sept. 4, 2026 | Paul Elliot Mann Chairman and CEO, director | Sold 10b5-1 plan | 83,759 | $4.10 | $343,412 |
| Sept. 3, 2026 | Paul Elliot Mann Chairman and CEO, director | Sold 10b5-1 plan | 83,758 | $3.92 | $328,331 |
| Sept. 2, 2026 | Donald George Ainscow EVP, Gen Counsel, Secretary | Sold | 23,678 | $3.89 | $92,107 |
| Sept. 2, 2026 | Robert Ainscow COO | Sold 10b5-1 plan | 25,000 | $3.91 | $97,625 |
| Sept. 2, 2026 | Paul Elliot Mann Chairman and CEO, director | Sold 10b5-1 plan | 83,758 | $3.91 | $327,494 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 21 →Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedASP Isotopes Says Renergen's Tetra4 Unit Achieves Stable Liquid Helium Production, Targets Nameplate Capacity in Q4 2026
Regulation FD disclosure · Financial statements and exhibits
Regulation FD disclosure